Sign in to continue:

Thursday, March 19th, 2026

Pineapple Financial Inc. 8-K Filing Details: Company Information, Address, and Voting Results (March 13, 2026)

Pineapple Financial Inc. Announces Results of 2026 Annual Meeting of Stockholders

Pineapple Financial Inc. (NYSE American: PAPL) has released its Form 8-K report detailing the proceedings and outcomes of its 2026 Annual Meeting of Stockholders, held on March 13, 2026. This report contains information that may be of interest to current and prospective investors, including board elections and auditor ratification.

Key Highlights from the Report

  • Date of Report: March 13, 2026
  • Type of Filing: Current Report (Form 8-K)
  • Trading Symbol: PAPL
  • Exchange: NYSE American
  • Emerging Growth Company: Pineapple Financial Inc. qualifies as an “Emerging Growth Company” under SEC rules, which may allow for reduced disclosure and compliance requirements.

Shareholder Meeting Results

At the 2026 Annual Meeting, shareholders considered and voted on two principal matters:

  1. Election of Directors

    Shareholders elected six directors to serve until the Company’s 2027 annual meeting or until their successors are duly elected and qualified. This confirms continuity in the board’s leadership and strategic direction. The directors elected were not specifically named in the filing, but their election suggests shareholder approval of current management and governance practices.

  2. Ratification of Independent Auditor

    Proxies were solicited for the ratification of MNP LLP as Pineapple Financial’s independent registered public accounting firm for the fiscal year ending August 31, 2026. Shareholders voted for, against, or withheld their votes for this proposal. The ratification of MNP LLP as auditor is a significant event, as it ensures continuity in financial oversight and reporting integrity.

Additional Items of Potential Interest

  • The company’s common shares (no par value) remain listed on the NYSE American under the symbol PAPL.
  • The report confirms the company is not engaging in any written communications, soliciting materials, or pre-commencement tender offers under relevant SEC rules at this time. This means there are no imminent merger, acquisition, or tender offer activities disclosed in this filing.
  • No amendments to previously filed reports are indicated, with the “Amendment Flag” set to false.
  • Pineapple Financial Inc. has not elected to use the extended transition period for complying with new or revised financial accounting standards, which means it will adopt new standards as they become effective.

What Investors Should Know

  • Board stability: The successful election of the six directors provides stability and continuity, which may support investor confidence in the company’s strategic direction.
  • Auditor ratification: The ratification of MNP LLP as auditor is generally a positive sign for investors, as it demonstrates trust in the firm’s financial oversight and audit practices.
  • No price-sensitive corporate actions: There are no disclosures of major corporate actions, such as mergers, acquisitions, or tender offers that would typically impact the share price at this time.

Conclusion

This Form 8-K filing from Pineapple Financial Inc. primarily serves as confirmation of the annual meeting’s routine outcomes. The continuity in board leadership and auditor selection may reinforce investor confidence, but no new material events or price-sensitive disclosures were made. The company’s status as an emerging growth company may affect future reporting and compliance, but is not expected to materially impact shares immediately.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review official SEC filings and consult with financial professionals before making investment decisions.

View Pineapple Financial Inc. Historical chart here



Caris Life Sciences 2025 Annual Report: Precision Oncology, Molecular Profiling, AI/ML Innovation, and Business Overview

Caris Life Sciences, Inc. 2025 Annual Report – Key Highlight...

lululemon athletica inc. 2025 Annual Report: Global Business Overview, Market Segments, and Growth Strategies

Lululemon Athletica Inc. FY2025 10-K: Key Highlights, Risks,...

ImmuCell Corporation Files Form 8-K with SEC Detailing Corporate Information and Press Release March 2026

ImmuCell Corporation Announces Board Changes and Director Ap...

   Ad